Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar:104:610-616.
doi: 10.1016/j.ijid.2021.01.034. Epub 2021 Jan 29.

Characterization of antibodies in human immunoglobulin products from different regions worldwide

Affiliations

Characterization of antibodies in human immunoglobulin products from different regions worldwide

Alexandra Serra et al. Int J Infect Dis. 2021 Mar.

Abstract

Aim: The antibody levels against a broad spectrum of pathogens were assessed in commercial intravenous immunoglobulin (IVIG) manufactured from pooled plasma obtained from different global regions.

Methods: Twenty-four IVIG commercial lots from eight manufacturers corresponding to 12 brands were analyzed. The plasma was collected in 10 countries/regions. Depending on each pathogen, antibody levels were measured using specific commercial IgG-specific enzyme immunoassay kits or by cell culture neutralization test and guinea pig skin neutralization test. A principal component analysis was performed.

Results: For polio and diphtheria (reference markers of the US authorities), all IVIGs had relevant titers in accordance with reference levels. IVIGs from Canada, Australia, and the USA were positive for titers against globally distributed pathogens or those under vaccination programs in the developed world (parainfluenza, Epstein-Barr, varicella-zoster, influenza B, parvovirus B19, and measles viruses). IVIG from Taiwan and Hong Kong showed low antibody titers for these pathogens but high titers for Pseudomonas aeruginosa. IVIG from India had high titers for pathogens frequently found in developing countries (West Nile, dengue, chikungunya, and hepatitis E viruses and Streptococcus pneumoniae). IVIGs from Argentina, Spain, Israel, and Czechia showed intermediate antibody concentrations.

Conclusion: The antibody profile in IVIG was greatly influenced by regional characteristics including climate, vaccination programs, and the prevalence of pathogens in the different countries and regions.

Keywords: Antibody titer; Blood plasma; Intravenous immunoglobulin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Principal component analysis (PCA) plot of the first two components, showing a clear separation of four groups of intravenous immunoglobulin preparations based on their antibody titers. Percentages of variation explained by each component are indicated along the axes. Argentina (ARG), Australia (AUS), Taiwan (TWN), Hong Kong (HKG), India (IND), Israel (ISR), Spain (SPN), Czechia (CZE), United States of America (USA), and Canada (CDA).

References

    1. Anukumar B., Sapkal G.N., Tandale B.V., Balasubramanian R., Gangale D. West Nile encephalitis outbreak in Kerala, India, 2011. J Clin Virol. 2014;61:152–155. - PubMed
    1. Audet S., Virata-Theimer M.L., Beeler J.A., Scott D.E., Frazier D.J., Mikolajczyk M.G., Eller N., Chen F.M., Yu M.Y. Measles-virus-neutralizing antibodies in intravenous immunoglobulins. J Infect Dis. 2006;194:781–789. - PubMed
    1. Bozzo J., Jorquera J.I. Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role. Expert Rev Anti Infect Ther. 2017;15:585–604. - PubMed
    1. Bruton O.C. Agammaglobulinemia. Pediatrics. 1952;9:722–728. - PubMed
    1. Cao W., Liu X., Bai T., Fan H., Hong K., Song H., Han Y., Lin L., Ruan L., Li T. High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with Coronavirus Disease 2019. Open Forum Infect Dis. 2020;7 - PMC - PubMed

LinkOut - more resources